ISB News

Former SEE intern Julia Joo thanks ISB

“I’m so grateful to ISB for giving me the opportunity to build the diverse lab-relevant skillset that made me a competitive candidate for research labs as an undergraduate,” said Julia Joo, who recently visited ISB and reflected on how her Systems Education Experiences internships shaped her academic and professional trajectory.

Julia JooIn 2013, Joo was a high school intern in ISB’s Hood Lab. In 2014, she came back for another internship, this time in the Huang Lab. Joo has since graduated from the University of Washington with a Biochemistry and Molecular, Cellular and Development Biology double major, and now she’s working at Seattle Children’s Research Institute Center for Immunity and Immunotherapies in the Miao Lab.

“With my experience in a cutting-edge research facility like ISB, I was able to be selective in choosing the lab I decided to join from those which offered me a position. I was incredibly fortunate to work on a project studying the sub-clonal variation of mutation spectra in glioblastoma tumors with Dr. Lawrence Loeb, the pioneer of the mutator phenotype hypothesis of cancer. I have ISB to thank for this experience, as I initially encountered Dr. Loeb’s work at the annual ISB Symposium in 2013, at which he was a keynote speaker.”

“Even years after my internship, I am constantly struck by the relevance of ISB’s mantra of using interdisciplinary methods to illuminate the complex networks of disease. The systems approach to biomedicine motivates me to learn new techniques across disciplines and deepen my understanding of coding languages so I can be better equipped to tackle the hurdle of heterogeneity of diseases between and within individual patients.”

“I am fascinated by the bridge between research and patient care, and thus am very excited to dive into the world of translational research as a Research Scientist in Dr. Carol Miao’s lab at the Seattle Children’s Research Institute. I’m thrilled to be designing immunotherapies for genetic diseases like hemophilia, knowing that my work will soon lead to real treatments that will help kids and adults alike to live safer and healthier lives.”

Recent Articles

  • Understanding, Preventing and Treating Long-Term Effects of COVID: RECOVER Study Enrolling Patients from Pacific Northwest

    As part of a massive nationwide effort, ISB is leading a multi-site consortium for the NIH RECOVER (Researching COVID to Enhance Recovery) Initiative. The Pacific Northwest consortium is made up of ISB, Providence, Swedish, and University of Washington School of Medicine.

  • Spotlight on ISB Education graphic

    2021-22 School Year ISB Education Highlights

    From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2021-2022 academic year, we will highlight some of the top projects the team is working on.

  • Jim Heath AACR Academy Fellow

    Dr. Jim Heath Named Fellow of AACR Academy Class of 2022

    Dr. Jim Heath was announced as a newly elected Fellow of the American Academy for Cancer Research (AACR) Academy Class of 2022. “I am honored and humbled to be recognized as part of this renowned group of researchers who have done so much to move our understanding of cancer forward,” Heath said.